| 1. |
Maria W Inger CM, Pascal WH, et al. Central serous chorioretinopathy[J]. Acta Ophthalmol, 2008, 86(2): 126-145.
|
| 2. |
趙明威. 努力探索發病機制,進一步提升治療水平:中心性漿液性脈絡膜視網膜病變研究的現實與挑戰[J]. 中華眼底病雜志, 2011, 27(4): 305-308.
|
| 3. |
Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy[J]. Ophthalmology, 1995, 102(5): 737-747.
|
| 4. |
TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy(TAP) study group[J]. Arch Ophthalmol, 1999, 117(10): 1329-1345.
|
| 5. |
Allison BA, Pritchard PH, Levy JG. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative[J]. Br J Cancer, 1994, 69(5): 833-839.
|
| 6. |
Engbrecht BW, Menon C, Kachur AV, et al. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model[J]. Cancer Res, 1999, 59(17): 4334-4342.
|
| 7. |
Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography[J]. Retina, 2010, 30(5): 801-809.
|
| 8. |
劉曉玲, 林冰, 瞿佳. 中心性漿液性脈絡膜視網膜病變的吲哚青綠和熒光素眼底血管造影[J]. 中華眼底病雜志, 2000, 16(1): 14-16.
|
| 9. |
Lim JI, Flower RW. Indocyanine green angiography[J]. Int Ophthalmol Clin, 1995, 35(4): 59-70.
|
| 10. |
陸方, 嚴密. 中國眼底病論壇暨老年性黃斑變性暨糖尿病視網膜病專題研討會論文集[G]. 上海, 2008. 中華醫學會眼科學分會, 北京: 2008.
|
| 11. |
Liew G, Quin G, Gillies M, et al. Central serous chorioretinopathy: a review of epidemiology and pathophysiology[J]. Clin Experiment Ophthalmol, 2013, 41(2): 201-214.
|
| 12. |
Chan WM, Lam DS, TYY Lai, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level[J]. Br J Ophthalmol, 2003, 87(12): 1453-1458.
|
| 13. |
Schmidt-Erfurth U, Michels S, Barbazetto I, et al. Photodynamic effects on choroidal neovascularization and physiological choroid[J]. Invest Ophthalmol Vis Sci, 2002, 43(3): 830-841.
|
| 14. |
Hajishengallis G, Arce S, Gockel CM, et al. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections[J]. J Dent Res, 2005, 84(12): 1104-1116.
|
| 15. |
Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003[J]. Retina, 2012, 32 (Suppl 1): 288-298.
|
| 16. |
Cardillo Piccolino F, Eandi CM, Ventre L, et al. Photodynamic therapy for chronic central serous chorioretinopathy[J]. Retina, 2003, 23: 752-763.
|
| 17. |
Chan WM, Lai TY, Lai RY, et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study[J]. Retina, 2008, 28(1): 85-93.
|
| 18. |
Haimovici R, Kramer M, Miller JW, et al. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye[J]. Curr Eye Res, 1997, 16(2): 83-90.
|
| 19. |
Reibaldi M, Boscia F, Avitabile T, et al. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy[J]. Eur J Ophthalmol, 2009, 19(1): 154-158.
|
| 20. |
Zhao MW, Zhou P, Xiao HX, et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin[J]. Retina, 2009, 29(8): 1155-1161.
|
| 21. |
lnoue R, Sawa M, Tsujikawa M, et al. Association between the efficacy of photodynamic therapy and indocyanine green angiograph findings for central serous chorioretinopathy[J]. Am J Ophthalmol, 2009, 149: 441-446.
|
1/5
微信公眾號